CAMBIAR INVESTORS LLC

Position in NVO — Novo Nordisk A S

CIK 823621 Denver, CO

Position in NVO

as of Jun 30, 2026 · filed Jul 31, 2026 Compact

Position Value

$14,091,148

+$1,842,631 QoQ

Shares Held

293,933

-11.8% QoQ

Ownership

0.007%

of shares outstanding

% of Portfolio

0.63%

of 13F equity value

Holder Rank

#128

of 1,348 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 99% Shared 0% None 1%

Healthcare · as of Jun 30, 2026

CAMBIAR INVESTORS LLC holds $97,555,817 across 4 Drug Manufacturers - General names. NVO ranks #3 (14.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BMY	Bristol Myers Squibb Co	1,017,517	$58,629,329
2	AZN	Astrazeneca PLC	129,899	$24,631,448
3	NVO	Novo Nordisk A S This page	293,933	$14,091,148
4	NVS	Novartis AG	1,301	$203,892

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$14,091,148	293,933	-11.8%	Shares	Sole	2026-07-31
2026-03-31	$12,248,517	333,293	—	Shares	Sole	2026-05-12
No filing history on record for this holder in this stock.